Glenmark Life Sciences Limited (GLS.BO)
INR 1021.7
(-0.42%)
INR 1021.7
(-0.42%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 4.7 Billion INR | 0.84% |
| 2022 | 4.66 Billion INR | 11.52% |
| 2021 | 4.18 Billion INR | 19.1% |
| 2020 | 3.51 Billion INR | 12.29% |
| 2019 | 3.13 Billion INR | 6.98% |
| 2018 | 2.92 Billion INR | 67536.18% |
| 2017 | -4.34 Million INR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 953.16 Million INR | -14.5% |
| 2024 Q1 | 1.11 Billion INR | 13.83% |
| 2023 Q1 | 1.35 Billion INR | -7.45% |
| 2023 FY | 4.7 Billion INR | 0.84% |
| 2023 Q3 | 1.18 Billion INR | 0.02% |
| 2023 Q2 | 1.18 Billion INR | -12.34% |
| 2023 Q4 | 979.36 Million INR | -17.54% |
| 2022 Q1 | 1.08 Billion INR | 9.95% |
| 2022 FY | 4.66 Billion INR | 11.52% |
| 2022 Q4 | 1.46 Billion INR | 39.4% |
| 2022 Q3 | 1.04 Billion INR | -1.76% |
| 2022 Q2 | 1.06 Billion INR | -1.71% |
| 2021 Q1 | 1 Billion INR | -3.6% |
| 2021 Q2 | 1.15 Billion INR | 14.16% |
| 2021 Q3 | 1.03 Billion INR | -9.97% |
| 2021 Q4 | 988.97 Million INR | -4.64% |
| 2021 FY | 4.18 Billion INR | 19.1% |
| 2020 FY | 3.51 Billion INR | 12.29% |
| 2020 Q4 | 1.04 Billion INR | 12.13% |
| 2020 Q3 | 933.61 Million INR | 28.83% |
| 2020 Q2 | 724.7 Million INR | -10.6% |
| 2020 Q1 | 810.66 Million INR | 0.0% |
| 2019 FY | 3.13 Billion INR | 6.98% |
| 2018 FY | 2.92 Billion INR | 67536.18% |
| 2017 FY | -4.34 Million INR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Ajanta Pharma Limited | 8.16 Billion INR | 42.305% |
| Amrutanjan Health Care Limited | 449.72 Million INR | -947.055% |
| Sigachi Industries Limited | 571.8 Million INR | -723.516% |
| Bal Pharma Limited | 73.92 Million INR | -6270.066% |
| Ind-Swift Laboratories Limited | 4.2 Billion INR | -11.86% |
| Medico Remedies Limited | 82.9 Million INR | -5579.576% |
| Lasa Supergenerics Limited | -217.3 Million INR | 2266.935% |
| Venus Remedies Limited | 284.9 Million INR | -1552.772% |
| Sun Pharma Advanced Research Company Limited | -3.87 Billion INR | 221.609% |
| Alpa Laboratories Limited | 167.76 Million INR | -2706.831% |
| Nectar Lifesciences Limited | 49.95 Million INR | -9327.187% |
| Shilpa Medicare Limited | 318.74 Million INR | -1377.333% |
| Aarti Drugs Limited | 1.71 Billion INR | -174.701% |
| Lupin Limited | 19.14 Billion INR | 75.404% |
| Aurobindo Pharma Limited | 31.72 Billion INR | 85.159% |
| Zydus Lifesciences Limited | 38.59 Billion INR | 87.799% |
| Windlas Biotech Limited | 581.87 Million INR | -709.267% |
| Suven Life Sciences Limited | -1.05 Billion INR | 548.139% |
| Eris Lifesciences Limited | 3.91 Billion INR | -20.13% |
| Valiant Laboratories Limited | 3.19 Million INR | -147236.671% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.52 Billion INR | 14.791% |
| Solara Active Pharma Sciences Limited | -5.67 Billion INR | 182.992% |
| Ipca Laboratories Limited | 5.47 Billion INR | 13.969% |
| Bliss GVS Pharma Limited | 754.54 Million INR | -524.072% |
| Achyut Healthcare Limited | 5.73 Million INR | -82050.733% |
| Sun Pharmaceutical Industries Limited | 95.76 Billion INR | 95.083% |
| Bajaj HealthCare Limited | -837.93 Million INR | 661.965% |
| RPG Life Sciences Limited | 876.6 Million INR | -437.175% |
| Mankind Pharma Limited | 19.12 Billion INR | 75.384% |
| Laurus Labs Limited | 1.6 Billion INR | -193.297% |
| Piramal Pharma Limited | 178.2 Million INR | -2542.469% |
| Syncom Formulations (India) Limited | 253.14 Million INR | -1760.173% |
| Torrent Pharmaceuticals Limited | 16.56 Billion INR | 71.571% |
| Alembic Pharmaceuticals Limited | 6.15 Billion INR | 23.535% |
| Glenmark Pharmaceuticals Limited | -15.01 Billion INR | 131.358% |
| Unichem Laboratories Limited | -704.74 Million INR | 768.17% |
| Sequent Scientific Limited | -358.69 Million INR | 1412.799% |
| Novartis India Limited | 851.9 Million INR | -452.75% |
| Wanbury Limited | 559.56 Million INR | -741.528% |
| Suven Pharmaceuticals Limited | 3 Billion INR | -56.816% |
| Wockhardt Limited | -4.63 Billion INR | 201.704% |
| Themis Medicare Limited | 435.23 Million INR | -981.909% |
| Jagsonpal Pharmaceuticals Limited | 224.63 Million INR | -1996.283% |
| Jubilant Pharmova Limited | 771 Million INR | -510.75% |
| Dr. Reddy's Laboratories Limited | 55.68 Billion INR | 91.544% |
| Divi's Laboratories Limited | 16 Billion INR | 70.57% |
| NATCO Pharma Limited | 13.88 Billion INR | 66.082% |
| Gufic Biosciences Limited | 861.35 Million INR | -446.682% |
| IOL Chemicals and Pharmaceuticals Limited | 1.34 Billion INR | -250.285% |
| Ind-Swift Limited | 142.31 Million INR | -3208.819% |
| Procter & Gamble Health Limited | 2 Billion INR | -134.296% |
| FDC Limited | 3.05 Billion INR | -54.277% |
| Krebs Biochemicals & Industries Limited | -197.28 Million INR | 2486.853% |
| Granules India Limited | 4.05 Billion INR | -16.18% |
| Medicamen Biotech Limited | 109.31 Million INR | -4207.822% |
| Alkem Laboratories Limited | 17.95 Billion INR | 73.778% |
| AstraZeneca Pharma India Limited | 1.61 Billion INR | -191.553% |
| Biofil Chemicals and Pharmaceuticals Limited | 7.09 Million INR | -66297.067% |
| Brooks Laboratories Limited | -195.91 Million INR | 2503.483% |
| Megasoft Limited | -127.46 Million INR | 3794.224% |
| ZIM Laboratories Limited | 172.46 Million INR | -2630.355% |
| Strides Pharma Science Limited | -706.14 Million INR | 766.848% |
| Neuland Laboratories Limited | 3 Billion INR | -56.921% |
| Morepen Laboratories Limited | 961.59 Million INR | -389.693% |
| Hikal Limited | 696.02 Million INR | -576.544% |
| Indoco Remedies Limited | 984.6 Million INR | -378.253% |
| Aarti Pharmalabs Limited | 2.16 Billion INR | -117.097% |
| Kilitch Drugs (India) Limited | 146.01 Million INR | -3124.951% |
| Mangalam Drugs & Organics Limited | -90.71 Million INR | 5290.736% |
| Hester Biosciences Limited | 188.89 Million INR | -2392.922% |